FDA approves a pill for herpes sores that won't heal
Published
Hovilpri (pritelivir) is for adults with weakened immune systems whose herpes lesions didn't respond to standard antivirals. In its trial, 63% healed fully within four weeks, compared with 34% on other treatments.
Source: Drug Topics
This is a plain-language summary. Read the original source for full details.